Biocartis Group NV

Major Shareholding Notification • Jun 4, 2015

FORM TR-1 BE PARTI

1) Status of the notification
	Final
2) Issuer
		$\sim$
Identification number 0505-640-808	Name BIOCARTIS
3) Reason for the notification
	Holding of voting securities upon first admission to trading
4) Notification by
	A parent undertaking or a controlling person
5) Persons subject to the notification requirement
	Name
	(& legal form for legal persons)	Address (for legal persons)
	Johnson & Johnson Innovation - JJDC, Inc.	410 George Street, New Brunswick, NJ 08901 USA
	Johnson & Johnson	1 J&J Plaza, New Brunswick, NJ 08901 USA
	6) Persons that dispose of, voting rights (Only to be filled in if art. 7 of the Law applies) Name (& legal form for legal persons)	Address (for legal persons)
	Please continue entering the information in part II concerning the	Click persons referred to in points 5 and 6
7) Date on which the threshold is crossed
	4/27/2015	(DD/MM/YYYY)
8) Threshold that is crossed (in %)
	15
		If the holding has fallen below the lowest threshold, you have the option of not entering any numbers under point 10
9) Denominator
	39,144,013
	Please enter the denominator before filling in the data

10) Notified details

A) Voting rights	Previous notification		After the transaction
	# of voting rights		# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Johnson & Johnson				0.00%
Johnson & Johnson Innovation - JJDC. Inc.		6,107,518		15.60%
subtotal		6,107,518		15,60%
TOTAL		6,107,518	0	15.60%	0.00%

Start with "groups" of holders, Calculate subtotals and then finish with the -
- The totals, subtotals and % will be updated once you have clicked on
-
CALCULATE>

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights
	TOTAL		(in relation to all expiration dates)	0	0.00%

$\blacklozenge$

The totals will be updated once you have clicked on

TOTAL (Voting rights & Equivalent financial linstruments)		# of voting rights	% of voting rights
	CALCULATE	6.107.518	15.60%

11) Chain of controlled undertakings through which the holding is effectively held, if applicable

Please describe, or join a diagram in attachment

Johnson & Johnson Innovation--JJDC, Inc., is a whollly owned subsidiary of Johnson & Johnson.
Johnson & Johnson is not a controlled entity.

12) In case of proxy voting for only one GM

Holder

will cease to hold /
will hold again

٥l

voting rights as of

13) Additional information

	A) Convertible bonds and rights to subscribe to voting securities not yet issued
Holder	Type of financial instrument	Expiration date (DD/MM/YYYY)	Exercise/Conversion period or date	Number	# of voting rights that may be acquired if the instrument is exercised/converted
B) Shares without voting rights
Holder	Number
C) Remarks
	This transparency notification is made to the extent required in accordance with applicable law.
Done at	New Brunswick, NJ USA
On		1/06/2015 (DD/MM/YYYY)
Name & capacity	Salvatore Glovine, Asst Treasurer, Johnson &		$C$ lanatura

Salvarore Giovine, Asst Treasurer, Johnson &
Johnson Innovation-JJDC, Inc.
Lacey Eiberg, Asst. Corporate Secretary, Johnson &
Johnson

Signature Signature

FORM TR-1 BE PARTI

$\sqrt{1}$
1) Status of the notification
	Final
2) Issuer
Identification number 0505-640-808	Name BIOCARTIS
3) Reason for the notification
	Holding of voting securities upon first admission to trading
4) Notification by
	A parent undertaking or a controlling person
5) Persons subject to the notification requirement
	Name (& legal form for legal persons)	Address (for legal persons)
	Johnson & Johnson Innovation - JJDC, Inc.	410 George Street, New Brunswick, NJ 08901 USA
	Johnson & Johnson	1 J&J Plaza, New Brunswick, NJ 08901 USA
	Name (& legal form for legal persons)	Address (for legal persons)
	Please continue entering the information in part II concerning the persons referred to in points 5 and 6	Click
7) Date on which the threshold is crossed
	4/27/2015	(DD/MM/YYYY)
8) Threshold that is crossed (in %)
	15
		If the holding has fallen below the lowest threshold, you have the option of not entering any numbers under point 10
9) Denominator
	39,144,013
	Please enter the denominator before filling in the data

10) Notified details

A) Voting rights	Previous notification	After the transaction
	# of voting rights		# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Johnson & Johnson				0.00%
Johnson & Johnson Innovation - JJDC, Inc.		6,107,518		15.60%
subtotal		6,107,518		15.60%
TOTAL		6,107,518	0	15.60%	0.00%

Start with "groups" of holders. Calculate subtotals and then finish with the t with "groups" of holders. Calculate subtotals and then imisit who investigated
____________________________________

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights
	TOTAL		(in relation to all expiration dates)	o	0.00%

The totals will be updated once you have clicked on

TOTAL (Voting rights & Equivalent financial instruments)		# of voting rights	% of voting rights
	CALCULATE	6,107,518	15.60%

11) Chain of controlled undertakings through which the holding is effectively held, if applicable

Please describe, or join a diagram in attachment

Johnson & Johnson Innovation-JJDC, Inc., is a whollly owned subsidiary of Johnson & Johnson.
Johnson & Johnson is not a controlled entity.

12) In case of proxy voting for only one GM

Holder

will cease to hold / will hold again

$|0|$

voting rights as of

$\bullet$

13) Additional information

A) Convertible bonds and rights to subscribe to voting securities not yet issued
Holder	Type of financial instrument	Expiration date (DD/MM/YYYY)	Exercise/Conversion period or date	Number	# of voting rights that may be acquired if the instrument is exercised/converted

B) Shares without voting rights
Holder	Number

C) Remarks
	This transparency notification is made to the extent required in accordance with applicable law.
Done at	New Brunswick, NJ USA
On	1/06/2015	(DD/MM/YYYY)
Name & capacity
	Salvatore Giovine, Asst Treasurer, Johnson & Johnson Innovation--JJDC, Inc.	Signature	$\mathbf{m}$ .
	Lacey Elberg, Asst. Corporate Secretary, Johnson & Johnson	Signature